Reaction

Cardiac Hypertrophy reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 1,094 reports · 14 co-occurring drugs

As of the last recalculation, Cardiac Hypertrophy appears in 1,094 FAERS reports alongside 14 co-occurring drug terms. The strongest observed disproportionality signal is AGALSIDASE BETA (PRR 50.5).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Agalsidase Beta2450.550.6
Dalteparin Sodium1425.525.5
Amphetamine818.518.5
Doxepin917.017.0
Tafamidis813.013.0
Eplerenone812.012.0
Oxazepam1311.611.6
Atazanavir810.710.7
Methadone2210.010.0
Ethyl Alcohol139.29.2
Isopropyl Alcohol148.08.0
Alcohol157.47.4
Minoxidil Foam 5% (Womens)127.07.0
Minoxidil125.15.1

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.